ライフサイエンスコーパス: corporate

1 izational level (i.e., global, national, and corporate).

2 eveloping comprehensive legal frameworks for corporate accountability in food governance.

3 ubsidy design, national income accounts, and corporate accounts.

4 on with potential to redirect and accelerate corporate action, to the benefit of business, people and

5 , internal technology transfer, and external corporate activism.

6 t of interest safeguards, monitor and expose corporate activities, debunk corporate arguments, and le

7 d-harm" efforts seem supportive of a similar corporate agenda.

8 siness supplier, suggesting that large-scale corporate agreements are necessary to make corn oil fryi

9 database contains ring structures from both corporate and commercial databases, along with character

10 f our approach by exploring the influence of corporate and foundation funding on the production and d

11 t clonal research and development, strategic corporate and government land-use policies, and rigorous

12 ls in efficient social structures in various corporate and governmental settings.

13 dvances in digital dentistry, development of corporate and group practice models, and integration of

14 , as are the implications of MFA results for corporate and national policy.

15 uccession, and in (legal) perpetuity (as for corporate and sovereign debts and specified assets).

16 icantly on the stage of development (in both corporate and technology) of the physician entrepreneur'

17 ians; leaders in the life insurance, private corporate, and prepaid health care industries; and medic

18 by a widespread skepticism of governmental, corporate, and professional dominance; unprecedented eco

19 f various individuals as well as government, corporate, and university sponsors of scientific work.

20 itor and expose corporate activities, debunk corporate arguments, and leverage diverse commercial int

21 cost implications of enforcing the national Corporate Average Fuel Economy (CAFE) and greenhouse gas

22 The United States Corporate Average Fuel Economy (CAFE) standards and Gree

23 Recent increases in the Corporate Average Fuel Economy standards have led to wid

24 Profit thus provides a discipline on corporate behavior, encouraging efficient performers, an

25 cribed commercial determinants of health and corporate behaviour, an immense effort will be needed to

26 ng answers to infrequent research questions, corporate bioinformatics is breaking down under the floo

27 ify six observed features of change towards 'corporate biosphere stewardship', with significant poten

28 ries of ocean use by taking on the mantle of corporate biosphere stewardship.

29 .g., juries, college admissions officers, or corporate boards) with the hope that a collective proces

30 (FAO) to tackle the problems related to the corporate capture of food governance, this article calls

31 icy makers to identify and close the gaps in corporate carbon footprints.

32 an urban area, and 85% were part of a larger corporate chain.

33 Enrollments in Personal Pledge and Corporate Challenge were associated with additional mean

34 nd 2 booster challenges (Personal Pledge and Corporate Challenge).

35 luence, time-bound goals, and convergence of corporate change.

36 -control policy instruments have, along with corporate citizenship, been the predominant means for br

37 Carbon credits feature prominently in corporate climate strategies and have sparked public deb

38 Third, building on relatedness and corporate coherence metrics, we introduce a measure of e

39 roximately 100,000 compounds from the AbbVie corporate collection and identified 24 chemotypes with a

40 We screened our corporate collection for DNA-PKcs inhibitors with good P

41 High throughput screening of our corporate collection led to the identification of 1, ada

42 requires a search for similar compounds in a corporate collection or from commercial suppliers.

43 Screening of the GSK corporate collection, some 1.9 million compounds, agains

44 d small-to-medium private practices; and the corporate commercial hospital sector, which is growing r

45 es, incentives for replacing old trucks, and corporate commitments towards electrification.

46 ine socioeconomic impact trends arising from corporate, community and diversified funding structures.

47 scribes the different and common features of corporate compared to academic environments, and highlig

48 , FPL 55712 analogs, and random screening of corporate compound banks.

49 ock solutions of compounds registered in the corporate compound collection as synthetic reactants.

50 H4 receptor, a high throughput screen of our corporate compound collection identified compound 6 as a

51 the phenotypic screening of the AstraZeneca corporate compound collection, N-aryl-2-aminobenzimidazo

52 by in silico similarity searches within the corporate compound deck based on rh-renin active site do

53 a high-throughput screening (HTS) hit of our corporate compound library, multiple parameter improveme

54 ees (39%), corporate grant recipients (34%), corporate consultants (23%), or shareholders (18%) of th

55 Microbiology (ASM) in collaboration with its Corporate Council and Clinical and Public Health Microbi

56 ic Health Microbiology Committee (CPHMC) and Corporate Council, provides a unique interactive platfor

57 atives from the companies that make up ASM's Corporate Council.

58 AI talent who can create value by leveraging corporate data to tackle crucial business problems.

59 were linked to administrative data in the VA Corporate Data Warehouse and activity-based cost data st

60 the national Veterans Health Administration Corporate Data Warehouse and Central Cancer Registry.

61 between 2017 and 2019 using Veterans Affairs Corporate Data Warehouse and Homeless registry data.

62 Data were obtained from the Veterans Affairs Corporate Data Warehouse and the Centers for Medicare &

63 We searched the VA national Corporate Data Warehouse and the National Death Index fo

64 tained from the Veterans Affairs system-wide Corporate Data Warehouse and the National Death Index.

65 ED encounter data were obtained from the VA Corporate Data Warehouse and the Office of Integrated Ve

66 PPr using the Veterans Health Administration corporate data warehouse and to evaluate national antibi

67 ficile (toxin or toxin genes) within the VHA Corporate Data Warehouse between 2011 and 2014.

68 Data were obtained from the VA Corporate Data Warehouse between January 1, 2000, and Oc

69 ment from the Veterans Health Administration Corporate Data Warehouse between January 1, 2004, and De

70 eterans Health Administration (VHA) system's Corporate Data Warehouse containing electronic medical r

71 tudy used US Department of Veterans Affairs' Corporate Data Warehouse data from March 1, 2010, to Feb

72 Corporate data warehouse data were extracted using valid

73 irs Surgical Quality Improvement Program and Corporate Data Warehouse databases were queried for pati

74 1, 2017, through February 28, 2023, using VA Corporate Data Warehouse encounter data supplemented wit

75 ross-sectional study used data from the VA's Corporate Data Warehouse for fiscal years 2019 to 2021.

76 udy using the Veterans Health Administration Corporate Data Warehouse from 1999 to 2013 to evaluate (

77 Data extracted from the VA Corporate Data Warehouse included patient demographics,

78 ucted a retrospective cohort study using the Corporate Data Warehouse of the Veterans Health Administ

79 m the US Department of Veterans Affairs (VA) Corporate Data Warehouse on patients who underwent elect

80 were obtained from the Veterans Affairs (VA) Corporate Data Warehouse or Medicare claims files from t

81 t Program (representative sample) and the VA Corporate Data Warehouse surgical domain (100% of surgic

82 ement Program (systematic sample) and the VA Corporate Data Warehouse surgical domain (100% of surgic

83 This cohort study obtained data from the VA Corporate Data Warehouse to form a cohort of veterans wh

84 ctive cohort study used the Veterans Affairs Corporate Data Warehouse to identify 154 514 male vetera

85 from the Veterans Health Administration (VA) Corporate Data Warehouse to identify veterans with a Cal

86 ongitudinal population-based analysis of the Corporate Data Warehouse, a large-scale database of pati

87 he authors linked three data sources: the VA Corporate Data Warehouse, Centers for Medicare and Medic

88 The VHA Corporate Data Warehouse, Pharmacy Benefits Management d

89 rom the Veterans Health Administration (VHA) Corporate Data Warehouse, which incorporates data from 1

90 SA nares screening were obtained from the VA Corporate Data Warehouse.

91 from the US Veterans Health Administration's Corporate Data Warehouse.

92 sed VA and community care data from the VA's Corporate Data Warehouse.

93 rom the Veterans Health Administration (VHA) Corporate Data Warehouse.

94 th record (EHR) data in the Veterans Affairs Corporate Data Warehouse.

95 electronic medical record data from the VHA Corporate Data Warehouse.

96 re compiled for fiscal year 2018 from the VA Corporate Data Warehouse.

97 's National Health Laboratory Service (NHLS) Corporate Data Warehouse.

98 ission or transfer were obtained from the VA Corporate Data Warehouse.

99 nt data retrieved from the Veterans Affairs' Corporate Data Warehouse.

100 ied using the Veterans Health Administration Corporate Data Warehouse.

101 y 1000 bed-days, were obtained from the VA's Corporate Data Warehouse.

102 from the National Health Laboratory Service Corporate Data Warehouse.

103 graphic and clinical variables from the VA's Corporate Data Warehouse; evaluated incidence rates (IRs

104 sults from model selected molecules from the corporate database and seven computationally derived sma

105 s as a three-dimensional query to search our corporate database identified 718 compounds (hits).

106 Our initial HTVS results of the Janssen corporate database identified small focused libraries wi

107 hould reflect default risk of the underlying corporate debt.

108 onals with a strengthened basis to influence corporate decision making, particularly when linked to c

109 ion of environmental costs and benefits into corporate decision-making has enormous, but as yet unful

110 ate group practices to account for increased corporate dentistry, graduate debt, digitalization, and

111 s in the field of dentistry (i.e. increasing corporate dentistry, graduate debt, digitalization, and

112 nies serving both populations to control for corporate differences.

113 scalable approach to reducing plate waste in corporate dining environments.

114 Because of their scale, corporate dining settings have a major role to play in r

115 To minimize the amount of waste produced by corporate dining settings, waste produced by the consume

116 Corporate diversification allows for well-hidden financi

117 ssfully attract funding from individuals and corporate donors.

118 pic donations and in-kind contributions from corporate donors.

119 s carbon neutrality, however, is to quantify corporate emissions accurately.

120 al models could thus improve the accuracy of corporate emissions inventories and help prioritize prim

121 Considering corporate employees' lifestyles and the role of gene-env

122 iscuss another key tension in this case: the corporate enclosure of scientific data that has signific

123 he analysis highlights an intensification in corporate engagement with alternative protein developmen

124 At present, six corporate entities and lens designs are attempting to co

125 aim to identify the features and actions of corporate entities that can influence health.

126 Law could recognize nonhuman AI-led corporate entities.

127 hcare system allowed the actions of a single corporate entity to undermine the system's ethics withou

128 ursue successful and exciting careers in the corporate environment.

129 realizing a major breakthrough in reporting corporate environmental impacts and dependencies has nev

130 at retirement, especially if the returns on corporate equities are comparable with historical return

131 s restoration projects in low-risk areas and corporate finance towards areas with business presence.

132 We also calculated the Corporate Financial Influence Index (CFII) for each coun

133 RSNA abstracts in which authors disclosed corporate financial relationships were twice as likely a

134 on of deepening public partnerships with the corporate food sector on an international scale.

135 ciated incentives, profits, and advertising; corporate food vending and associated incentives and pro

136 'enfance, the Fondation du Souffle, the SCOR Corporate Foundation for Science, the Battersea & Bowery

137 vernment agencies, and litigation; promoting corporate-friendly governance models, forms of regulatio

138 Second, and more importantly, that corporate funding influences the actual thematic content

139 First, that organizations with corporate funding were more likely to have written and d

140 2)-equivalence standards to coherently track corporate GHG emissions and their exposure to transition

141 While inventories used for public or corporate GHG policies have traditionally utilized botto

142 mal, involving universities, start-up firms, corporate giants, and venture capitalists play a major r

143 ter global norms and identities that contest corporate governance and the monopoly authority of state

144 s lens to include environmental, social, and corporate governance turns out to be good for business?

145 ograms can serve as benchmarks for community-corporate-government partnerships in the future.

146 s were for authors who were employees (39%), corporate grant recipients (34%), corporate consultants

147 gs), and social institutions (e.g., justice, corporate groups), and collectively constitute what I ca

148 esources that were controlled and managed by corporate groups.

149 ractitioners-both unlicensed and licensed-to corporate hospital chains and large private insurers.

150 For example, corporate icons, such as McDonald's Golden Arches, influ

151 ese emerging transformative projects can end corporate impunity and foster global norms and identitie

152 h was used to assess the association between corporate influence and policy implementation.

153 cracy, corporate permeation (an indicator of corporate influence), NCD burden, and risk factor preval

154 rocked by decades of political interference, corporate influence, mismanagement, and partisan efforts

155 strategies, grounded in an understanding of corporate influences on health, are necessary to promote

156 Data on corporate information and investment trends were extract

157 RE100 is the largest corporate initiative to foster RE procurement with 315 c

158 nd agendas decided by existing political and corporate institutions.

159 ic partnerships extend beyond a university's corporate interests to involve institutional decision ma

160 usual medical innovation ecosystem driven by corporate interests, not health outcomes.

161 d producers; protecting food governance from corporate interference; and implementing robust conflict

162 details about AI features, data storage, and corporate involvement were disclosed.

163 Duty information was provided from corporate IT systems.

164 ir views affect their decisions to climb the corporate ladder (or not).

165 In particular, we identify modern corporate law as a crucial system element that thus far

166 abilities in risk assessments, and recurring corporate lawsuits.

167 ch agenda to help scholars, policymakers and corporate leaders to identify the causal factors that sh

168 ing and screening of wealthy individuals and corporate leaders.

169 erability to supply restriction (VSR) at the corporate level for an invented solar cell manufacturing

170 at the national level for As and Au; at the corporate level, Se is highest with Te and Cu lower.

171 A corporate library of approximately 400 000 compounds was

172 ) studies of initial screening hits from our corporate library of compounds and a structurally relate

173 ATP competitive inhibitors from an internal corporate library.

174 n of paintings placed next to the sponsoring corporate logo, an effect that correlates with modulatio

175 Although the increase of corporate managed care has helped to reduce excesses and

176 Corporate management recognizes and responds naturally a

177 nonopioid pain management, ethical lapses in corporate marketing, historical stigmas directed against

178 iled, and little evidence was found in TTCs' corporate materials that snus is central to their busine

179 is success is attributable to government and corporate means to foster energy conservation in the cri

180 initiative to foster RE procurement with 315 corporate members as of 2021.

181 (AAO) Foundation Ophthalmic Business Council corporate members as reported in the annual 2019 meeting

182 e AAO Foundation Ophthalmic Business Council corporate members remain predominately male.

183 Corporate metabolisms are remarkably similar to those of

184 e are more than twice as likely to engage in corporate misconduct.

185 Assessments are made on corporate, national, and global levels for year 2008.

186 search Council template, is designed to help corporate, national, and global stakeholders conduct ris

187 e i-frame is a long-established objective of corporate opponents of concerted systemic action such as

188 ng employees who were recently hired, have a Corporate or Operations role, or work in shared office s

189 The contrast between the corporate organization at the base and top of Teotihuaca

190 ctor, investment owned, individual owned, or corporate owned.

191 research provides insights into the role of corporate ownership in health care relevant to policy ma

192 in fisheries is the limited transparency of corporate ownership.

193 The Genomation Laboratory, with corporate partners Orca Photonic Systems, Inc. and Engin

194 alized academic centers that form meaningful corporate partnerships to complement basic science infra

195 of capitalism nor a full-throated embrace of corporate partnerships.

196 based on international expenditures through corporate payment cards to map the network of global bus

197 policy implementation, including democracy, corporate permeation (an indicator of corporate influenc

198 For every unit increase in corporate permeation, implementation decreased by 5.0% (

199 plementation, but only in countries with low corporate permeation.

200 f NCDs, and to support countries facing high corporate permeation.

201 We illustrate how both corporate-philanthropic and food sovereignty networks ar

202 To counter this corporate playbook and advance health and wellbeing, pub

203 rategies to protect business interests-their corporate playbook-but many of these strategies come at

204 eate opportunities to explicitly counter the corporate playbook.

205 Shell, the only major corporate player in the field, recently developed two ve

206 ity in the drug industry is caused mainly by corporate policies that discourage innovation.

207 advancing policy responses is the industry's corporate political activities, coordinated transnationa

208 Existing conceptualisations of corporate political activity (CPA) are embedded in a bus

209 We used an existing model of corporate political activity, the Policy Dystopia Model,

210 rse than suggested by existing taxonomies of corporate political activity.

211 sed, accessible way of understanding diverse corporate political strategies.

212 global social relations in ways that reduce corporate power and empower civil society and local auth

213 bal response is essential-one that confronts corporate power, reclaims public policy space, and restr

214 al differences between Japanese and European corporate practice.

215 f chemical transparency policy decisions and corporate practices.

216 ind of dental practice they were working at (corporate, private, or academic institution), and if the

217 o mechanisms underlying T2D manifestation in corporate professionals due to genetics interacting with

218 tise health, equity, and sustainability over corporate profit.

219 Large-scale corporate projects, particularly those in extractive ind

220 Physician gender, obtained from the OHIP Corporate Provider Database.

221 edge, cluster randomized clinical trial of a corporate quality improvement initiative was conducted b

222 of 87 (32%) of 271 abstracts with disclosed corporate relationships discussed non-FDA-approved use o

223 This raises the possibility that corporate relationships may influence radiology research

224 Hence, corporate renewable electricity (RE) procurement may bec

225 be consistent with the beginnings of a wider corporate reorientation, occurring alongside a rise in p

226 e, we make use of unstructured financial and corporate reporting data in Japan as the base source to

227 isions toward better environmental outcomes, corporate reporting frameworks need to develop scientifi

228 Corporate reporting must embrace holistic, scientific pr

229 ned using multi-source features derived from corporate reports and Baidu Index trends.

230 case study of the tech sector, we find that corporate reports omit half of the total emissions.

231 ed promising points of intervention, whereas corporate researchers have performed the downstream, app

232 s deceleration are precariously dependent on corporate risk management, and public policies have reli

233 cation of novel antibacterial compounds from corporate screening collections, physical properties of

234 imally exploit the full potential of current corporate screening collections.

235 However, the corporate sector has remained the least explored for T2D

236 ty organisations, academic settings, and the corporate sector to focus on health outcomes and engage

237 ected are young professionals working in the corporate sector.

238 d directed support of the administration and corporate services.

239 es and platforms staff to administration and corporate services.

240 lators, an observation that has parallels in corporate settings where middle managers must interact m

241 s overly optimistic earnings forecasts after corporate site visits.

242 tween analysts and company executives during corporate site visits.

243 nt for issues beyond tobacco; and presenting corporate social responsibility (CSR) as an alternative.

244 Corporate social responsibility (CSR) research can help

245 ies to generate positive public relations is corporate social responsibility (CSR).

246 Switching from corporate social responsibility to what we term shared s

247 c arguments, rebrand political activities as corporate social responsibility, and establish and use t

248 nalyses of the language used by employees on corporate social-networking tools offer yet another way

249 In this paper, I address the case of a corporate society in Central Mexico.

250 omatoes: insights can be used to help inform corporate sourcing strategies and certification schemes.

251 ied limits on faculty financial interests in corporate sponsors of research, 12% (n = 11) specified l

252 researchers have financial interests in the corporate sponsors of their clinical research.

253 shallow pretreatment recession (< 4 mm), and corporate sponsorship all resulted in significantly (P <

254 n four times as much funding through greater corporate sponsorship and use of a wider variety of fina

255 rtners or competition among universities for corporate sponsorship that could erode academic standard

256 These, in turn, confer value to corporate stakeholders, providing incentives to bring ne

257 Government policies and corporate strategies aimed at reducing methane emissions

258 n, provided means for reflection, and guided corporate strategies and actions toward ocean stewardshi

259 Such network changes may reflect corporate strategies of each carrier.

260 of upstream policies designed to combat the corporate strategies used by the global sugar industry t

261 stakeholders, institutional reforms, diverse corporate strategies, and emergent societal practices an

262 the Oil and Gas Methane Partnership 2.0, and corporate strategies.

263 nal organisations through its well developed corporate strategies.

264 his forms part of a broader formula industry corporate strategy to widen the boundaries of illness in

265 mmunity funding structures are preferable to corporate structures, yet lack supporting quantitative d

266 100% higher socioeconomic impact levels than corporate structures.

267 influences other than economics, the path to corporate success is unlikely to be a compassionate one.

268 posed the fragility of highly interdependent corporate supply networks and the complex production pro

269 ematurely (645 patients; 299 SREs) after the corporate supporter withdrew study drug supply.

270 such as national income and wealth accounts, corporate sustainability reporting, land-use planning, a

271 ion for nickel mining are rarely included in corporate sustainability reports or considered in minera

272 decision making, particularly when linked to corporate values.

273 o boost implementation of policies targeting corporate vectors of NCDs, and to support countries faci

274 The industry interest in preserving corporate viability has affected the design and interpre

275 from the Department of Veterans Affairs (VA) Corporate Warehouse Data from 2015, we evaluated HIV, HC

276 A systematic review of corporate websites and Nexis Uni was performed, resultin

277 cialty, women remain underrepresented in the corporate world of ophthalmology.

278 t and leadership positions in the ophthalmic corporate world.